MAPKs and CDKs can form complex kinase networks to interact and regulate cell survival and death [22], the targeting of which might provide a novel strategy for cancer therapy via enhancement of CDK4/6i activity and reduction of tumor resistance. Here, CDK4 is linked to cancer.